16.12.2012 Views

Therapies for Children With Autism Spectrum Disorders

Therapies for Children With Autism Spectrum Disorders

Therapies for Children With Autism Spectrum Disorders

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Evidence Table. <strong>Therapies</strong> <strong>for</strong> children with ASD (continued)<br />

Study<br />

Description Intervention<br />

Author:<br />

Quirmbach et al.,<br />

2009<br />

Country:<br />

US<br />

Practice<br />

setting:<br />

Academic<br />

Intervention<br />

setting:<br />

Clinic<br />

Enrollment<br />

period:<br />

NR<br />

Funding:<br />

NR<br />

Author industry<br />

relationship<br />

disclosures:<br />

NR<br />

Design:<br />

RCT<br />

Intervention:<br />

Two social stories training<br />

sessions one week apart.<br />

Baseline and four other<br />

trials were completed<br />

each day. The last trial<br />

was a generalization trial,<br />

where games were<br />

switched.<br />

Assessments:<br />

Observation/direct<br />

assessment (ADOS,<br />

WISC-IV, PIAT-R);<br />

observation (turn-taking<br />

games 5 times per day in<br />

play room): total game<br />

playing skill score 0-8,<br />

2 points per skill<br />

(greeting behaviors,<br />

requesting to play a<br />

game, asking another<br />

person what they want to<br />

play, accepting another’s<br />

choice of game)<br />

Groups:<br />

G1: social story, standard<br />

condition (both training<br />

days)<br />

G2: social story, directive<br />

condition (both training<br />

days)<br />

G3: control story condition<br />

unrelated to social skills<br />

(control story first day,<br />

randomly assigned to<br />

either standard or<br />

directive story on the<br />

second day)<br />

G1a: G1 with VCI > 68<br />

G2a: G2 with VCI > 68<br />

G3a: G3 with VCI > 68<br />

G3s: G3a with standard<br />

second day<br />

G3d: G3a with directive<br />

second day<br />

Provider:<br />

Inclusion/ Exclusion<br />

Criteria/ Population<br />

Inclusion criteria:<br />

• ASD diagnosis<br />

Exclusion criteria:<br />

• Insufficient reading skills<br />

(less than first grade<br />

level on PIAT-R)<br />

Age, yrs ± SD (range):<br />

G1: 9.49 ± 2.09 (7-12)<br />

G2: 10.33 ± 2.53 (7-14)<br />

G3: 8.85 ± 1.59 (7-12)<br />

G1a: 9.49 ± 2.04 (7-12)<br />

G2a: 9.72 ± 2.61 (7-14)<br />

G3a: 8.79 ± 1.38 (7-11)<br />

Mental age:<br />

See IQ under baseline<br />

Gender, n (%):<br />

Male:<br />

G1: 14 (93)<br />

G2: 14 (93)<br />

G3: 14 (93)<br />

Female:<br />

G1: 1 (7)<br />

G2: 1 (7)<br />

G3: 1 (7)<br />

Race/ethnicity:<br />

NR<br />

SES:<br />

Maternal education: NR<br />

Household income: NR<br />

Diagnostic approach: NR<br />

Diagnostic tool/method:<br />

ADOS<br />

Diagnostic category, n<br />

(%):<br />

<strong>Autism</strong>: 42 (93)<br />

ASD: 3 (7)<br />

Other characteristics:<br />

NR<br />

C-85<br />

Baseline<br />

Measures Outcomes<br />

Sleep behavior:<br />

G1: 6.17 ± 7.14<br />

G2: 5.70 ± 8.56<br />

P = 0.85<br />

Harms<br />

NR<br />

Overall ratings:<br />

Modifiers<br />

NR<br />

Social skills:<br />

ADOS score, mean ± Total game<br />

SD:<br />

playing skills<br />

G1: 15.00 ± 4.99 score, mean ±<br />

G2: 14.40 ± 3.81 SD:<br />

G3: 15.60 ± 4.87 Day 1, trial 2:<br />

G1a: 11.90 ± 2.42 G1: 4.53 ± 3.48<br />

G2a: 12.60 ± 3.20 G2: 3.73 ± 2.96<br />

G3a: 13.20 ± 2.94 G3: NR<br />

Educational/cog- G1a: 6.30 ± 2.83<br />

nitive/academic G2a: 5.10 ± 2.60<br />

attainment: G3a: NR<br />

WISC-IV score, mean G3s: 2.40 ± 1.14<br />

± SD:<br />

G3d: 2.40 ± 1.14<br />

FSIQ:<br />

Day 1, trial 3:<br />

G1: 86.20 ± 22.80 G1: 4.53 ± 3.25<br />

G2: 81.00 ± 20.26 G2: 4.87 ± 2.90<br />

G3: 79.47 ± 22.68 G3: NR<br />

G1a: 98.80 ± 16.25 G1a: 6.40 ± 2.07<br />

G2a: 91.70 ± 14.87 G2a: 6.30 ± 2.45<br />

G3a: 91.50 ± 16.47 G3a: NR<br />

VCI:<br />

G3s: 2.80 ± 1.30<br />

G1: 82.07 ± 28.04 G3d: 2.20 ± 0.84<br />

G2: 79.33 ± 24.85 Day 1, trial 4:<br />

G3: 78.80 ± 27.86 G1: 4.07 ± 3.17<br />

G1a: 98.70 ± 17.32 G2: 5.07 ± 2.84<br />

G2a: 93.50 ± 16.34 G3: NR<br />

G3a: 95.10 ± 17.92 G1a: 5.90 ±2.03<br />

PRI:<br />

G2a: 6.40 ± 2.27<br />

G1: 99.47 ± 13.83 G3a: NR<br />

G2: 95.20 ± 13.18 G3s: 2.40 ± 1.67<br />

G3: 90.67 ± 18.89 G3d: 2.20 ± 0.84<br />

G1a: 103.20 ± 14.64 ANOVA (only<br />

G2a: 100.90 ± 8.49 trials 1-4):<br />

G3a: 97.80 ± 17.12 G1/G3: P < 0.05<br />

PIAT-R score, mean G2/G3: P < 0.05<br />

± SD:<br />

Improvement<br />

Reading recognition: across trials:<br />

G1: 4.09 ± 3.55 P < 0.001<br />

G2: 3.66 ± 3.00 G1a/G3a:<br />

G3: 2.49 ± 1.41 P < 0.001<br />

G1a: 5.36 ± 3.76 G2a/G3a:<br />

G2a: 4.29 ± 3.51 P < 0.001<br />

G3a: 2.96 ± 1.51 Improvement<br />

Reading<br />

across trials:<br />

comprehension: P < 0.001

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!